Citadel Advisors »

Corvus Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $91k 52k 1.76
2023-09-30 $71k 49k 1.46
2023-06-30 $140k 61k 2.29
2022-12-31 $11k 13k 0.85
2022-06-30 $44k 43k 1.02
2022-03-31 $793k 484k 1.64
2021-12-31 $418k 173k 2.42
2021-09-30 $2.7M 550k 4.84
2021-06-30 $190k 72k 2.65
2021-03-31 $436k 142k 3.07
2020-12-31 $51k 14k 3.54
2020-06-30 $42k 16k 2.71
2020-03-31 $95k 45k 2.10
2018-12-31 $62k 17k 3.67
2018-09-30 $180k 21k 8.47